_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > Human Cell Expressed > Mouse EDA2R / TNFRSF27 Protein

Mouse EDA2R / TNFRSF27 Protein (Cytokine) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
50411-M02H
  YES          

Protein Production & Purification Service

Ectodysplasin A2 receptor Protein Datasheet

 

EDA2R / TNFRSF27 Protein Price Inquiry ( Available Sizes )

EDA2R / TNFRSF27 Protein Product Information

Synonym : EDA2R,Tnfrsf27, Xedar
Protein Construction:

A DNA sequence encoding the mouse EDA2R (Q8BX35)(Met1-Thr138) was expressed, fused with the Fc region of human IgG1 at the C-terminus.

Source: Mouse
Expression Host: Human Cells

EDA2R / TNFRSF27 Protein QC Testing

Purity: > 95% as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

EDA2R / TNFRSF27 protein

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Met
Molecular Mass:

The recombinant mouse EDA2R /Fc is a disulfide-linked homodimer. The reduced monomer comprises 379 amino acids and has a predicted molecular mass of 42.4 kDa. The apparent molecular mass of the protein is approximately 49 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Formulation: Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

EDA2R / TNFRSF27 Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

EDA2R / TNFRSF27 Protein Related Products & Topics

Related Areas:

Immunology>>Cytokine & Receptor>>TNF Superfamily>>XEDAR/EDA2R/TNFRSF27

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
XEDAR/EDA2R Human EDA2R/XEDAR/TNFRSF27 Protein, Recombinant 11845-H08H
XEDAR/EDA2R Mouse EDA2R / TNFRSF27 Protein, Recombinant 50411-M02H
EDA2R Rat EDA2R / TNFRSF27 Protein, Recombinant 80206-R02H
EDA2R Rat EDA2R / TNFRSF27 Protein, Recombinant 80206-R08H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human
XEDAR/EDA2R
WB,ELISA Mouse Monoclonal Antibody 11845-MM05
Human
XEDAR/EDA2R
WB,ELISA Rabbit Polyclonal Antibody (Antigen Affinity Purified) 11845-RP02

EDA2R / TNFRSF27 Protein Description

Tumor necrosis factor receptor superfamily member 27, also known as X-linked ectodysplasin-A2 receptor, EDA-A2 receptor, EDA2R, XEDAR and TNFRSF27, is a single-pass type I II membrane protein. TNFRSF27 / EDA2R contains three TNFR-Cys repeats. It is a new member of the tumor necrosis factor receptor family that has been shown to be highly expressed in ectodermal derivatives during embryonic development and binds to ectodysplasin-A2 (EDA-A2). TNFRSF27 / EDA2R is a receptor for EDA isoform A2, but not for EDA isoform A1. TNFRSF27 / EDA2R mediates the activation of the NF-kappa-B and JNK pathways. The activation seems to be mediated by binding to TRAF3 and TRAF6. Ectodysplasin, a member of the tumor necrosis factor family, is encoded by the anhidrotic ectodermal dysplasia EDA gene. Mutations in EDA give rise to a clinical syndrome characterized by loss of hair, sweat glands, and teeth. EDA-A1 and EDA-A2 are two isoforms of ectodysplasin that differ only by an insertion of two amino acids. This insertion functions to determine receptor binding specificity, such that EDA-A1 binds only the receptor EDAR, whereas EDA-A2 binds only the related, but distinct, X-linked ectodysplasin-A2 receptor (XEDAR).

References

  1. Yan M. et al., 2000,Science. 290: 523-7.
  2. Sinha SK. et al., 2002, J Biol Chem. 277: 44953-61.
  3. Prodi DA. et al., 2008, J Invest Dermatol. 128 (9): 2268-70.